
|Articles|January 1, 2002
Botulinum toxin-A(ccuracy)
Munich - Dermatologists can objectively assess a patient's response to botulinum toxin-A treatment by using a digital camera and appropriate software, according to research recently published by Mark Heckmann, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














